End points in studies on the prevention of deep vein thrombosis

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 1, 2001, Pages 41-46

  Sonaglia, F ^a   Rossi, R ^a   Agnelli, G ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

D dimer; DVT; Impedance plethysmography; Ultrasonography; Venography

Indexed keywords

ENOXAPARIN; PLACEBO;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; HUMAN; IMPEDANCE PLETHYSMOGRAPHY; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHLEBOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0035112140     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12850     Document Type: Article

References (33)

1. Phlebography
2. Roengten diagnosis of venous thrombosis in the leg
3. Diagnosis of venous thrombosis
4. Percentage of inadequate phlebograms and observer agreement in thromboprophylactic multicenter trials using standardized methodology and central assessment
5. Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393
6. Prevention of thromboembolism with use of recombinant hirudin: Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement
7. The measurements of observer agreement for categorial data
8. Local versus central assessment of venographies in a multicenter trial on the prevention of deep vein thrombosis in neurosurgery
9. Enoxaparin plus compression stockings versus compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery
10. Risk of deep-vein thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomized comparison of enoxaparin versus placebo
11. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
12. Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin®)
13. Efficacy and safety of prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after total hip arthroplasty - The Danish Prolonged Prophylaxis (DaPP) study
14. 125I fibrinogen leg scanning in patients following hip surgery
15. Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery. A venography-controlled study
16. 125I Fibrinogen leg scanning: Reassessment of its role for the diagnosis of venous thrombosis in post-operative patients
17. Accuracy of ultrasound for the diagnosis of deep vein thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis
18. A comparison of compression ultrasound with color-Doppler ultrasound for the diagnosis of symptomless post-operative deep vein thrombosis
19. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to post-operative DVT, malignancy and stanozol treatment
20. Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement
21. Thrombin-antithrombin complex & fibrin-degradation products in plasma: Surgery and post-operative deep venous thrombosis
22. The value of Enzygnost TAT test in the diagnosis of post-operative deep vein thrombosis after hip surgery
23. Value of liquid crystal contact thermography and plasma level of D-dimer for screening of deep vein thrombosis following general abdominal surgery
24. Measurement of cross-linked fibrin derivatives in patients undergoing abdominal surgery: Use in the diagnosis of post-operative venous thrombosis
25. Plasma D-dimer as a marker for post-operative deep vein thrombosis. A study after total hip or knee arthroplasty
26. D-dimer plasma measurement in patients undergoing major hip surgery: Use in the prediction and diagnosis of postoperative proximal deep vein thrombosis
27. Clinical utility of prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimer measurement in the diagnosis of deep vein thrombosis following total hip replacement
28. Measurement of plasma D-Dimer is not useful in the prediction or diagnosis of postoperative deep vein thrombosis in patients undergoing total knee arthroplasty
29. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti II activities, and D-Dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery
30. Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography. An overview analysis
31. Death and thromboembolic disease after total hip replacement
32. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation
33. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge